Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a0665bed23a5783d3e99d6eddaeda66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7821f3986b15f9e950e977d7cb55abc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d58abb20be35c017743fcc9fcb520c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62f941494409aea84f621977c5f0ab81 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1098 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 |
filingDate |
2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_038c152cc1a0a83e575b0dcd7269d30c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f453739c959671b17cba04782e84170a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6416a66f0ee551b5c850a0f425650f6 |
publicationDate |
2014-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8895509-B2 |
titleOfInvention |
MIR-200 family induces mesenchymal-to-epithelial transition (MET) in ovarian cancer cells |
abstract |
The present invention provides a method of treating an ovarian cancer, the method comprising delivering one or more miR-200 family members to a mammalian subject in need thereof in an amount effective to treat the ovarian cancer. Also provided are methods of preventing metastasis of an ovarian cancer, the method comprising delivering one or more miR-200 family members to a mammalian subject in need thereof in an amount effective to prevent metastasis. Further provided are methods of sensitizing an ovarian cancer to a cytotoxic therapy, the method comprising delivering one or more miR-200 family members to a mammalian subject in need thereof in an amount effective to sensitize the ovarian cancer to the cytotoxic therapy. The invention also contemplates methods of reducing epithelial-to-mesenchymal transition (EMT) in an ovarian cancer or cancer cell as well as methods of inducing mesenchymal-to-epithelial transition (MET). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016377398-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534451-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017106926-A1 |
priorityDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |